secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kura Oncology, Inc. (KURA)
CIK:        0001422143
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001193125-23-166858
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kura Oncology prices $100M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering of 5,660,871 common shares at $11.50 and 3,034,782 pre-funded warrants at $11.4999 per warrant.
- Expected net proceeds of $93.6M; closing on June 16, 2023.
- Underwriters granted 30-day option to buy up to 1,304,347 additional shares.
- BofA Securities, Jefferies and SVB Securities are joint bookrunning managers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422143/000119312523166858/0001193125-23-166858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422143/000119312523166858/d507995d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-166858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer